{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:38:46Z","timestamp":1780861126526,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T00:00:00Z","timestamp":1143504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s00277-006-0085-5","type":"journal-article","created":{"date-parts":[[2006,3,27]],"date-time":"2006-03-27T13:49:28Z","timestamp":1143467368000},"page":"415-423","source":"Crossref","is-referenced-by-count":67,"title":["Von Willebrand factor and thrombosis"],"prefix":"10.1007","volume":"85","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,28]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","volume":"60","author":"HJ Weiss","year":"1977","unstructured":"Weiss HJ, Sussman II, Hoyer LW (1977) Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand\u2019s disease. J Clin Invest 60:390\u2013404","journal-title":"J Clin Invest"},{"key":"85_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/279636a0","volume":"279","author":"KS Sakariassen","year":"1979","unstructured":"Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII\u2013Von Willebrand factor bound to the subendothelium. Nature 279:636\u2013638","journal-title":"Nature"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.seminhematol.2004.09.009","volume":"42","author":"I Martinelli","year":"2005","unstructured":"Martinelli I (2005) Von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol 42:49\u201355","journal-title":"Semin Hematol"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1160\/TH04-03-0148","volume":"92","author":"M Franchini","year":"2004","unstructured":"Franchini M (2004) Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost 92:298\u2013304","journal-title":"Thromb Haemost"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.seminhematol.2004.09.008","volume":"42","author":"K Soejima","year":"2005","unstructured":"Soejima K, Nakagaki T (2005) Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies. Semin Hematol 42:56\u201362","journal-title":"Semin Hematol"},{"key":"85_CR6","first-page":"94","volume":"88","author":"G Castaman","year":"2003","unstructured":"Castaman G, Federici AB, Rodeghiero F, Mannucci PM (2003) Von Willebrand\u2019s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 88:94\u2013108","journal-title":"Haematologica"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","volume":"30","author":"DJ Mancuso","year":"1991","unstructured":"Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE (1991) Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 30:253\u2013269","journal-title":"Biochemistry"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1991.tb43697.x","volume":"614","author":"JE Sadler","year":"1991","unstructured":"Sadler JE, Mancuso DJ, Randi AM, Tuley EA, Westfield LA (1991) Molecular biology of von Willebrand factor. Ann NY Acad Sci 614:114\u2013124","journal-title":"Ann NY Acad Sci"},{"key":"85_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.seminhematol.2004.09.006","volume":"42","author":"GL Mendolicchio","year":"2005","unstructured":"Mendolicchio GL, Ruggeri ZM (2005) New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol 42:5\u201314","journal-title":"Semin Hematol"},{"key":"85_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","volume":"6","author":"DD Wagner","year":"1990","unstructured":"Wagner DD (1990) Cell biology of von Willebrand factor. Annu Rev Cell Biol 6:217\u2013246","journal-title":"Annu Rev Cell Biol"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00062752-200303000-00008","volume":"10","author":"ZM Ruggeri","year":"2003","unstructured":"Ruggeri ZM (2003) Von Willebrand factor. Curr Opin Hematol 10:142\u2013149","journal-title":"Curr Opin Hematol"},{"key":"85_CR12","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","volume":"100","author":"JF Dong","year":"2002","unstructured":"Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA (2002) ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100:4033\u20134039","journal-title":"Blood"},{"key":"85_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1473-0502(03)00046-6","volume":"28","author":"M Schmugge","year":"2003","unstructured":"Schmugge M, Rand ML, Freedman J (2003) Platelets and von Willebrand factor. Transfus Apher Sci 28:269\u2013277","journal-title":"Transfus Apher Sci"},{"key":"85_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/beha.2001.0133","volume":"14","author":"ZM Ruggeri","year":"2001","unstructured":"Ruggeri ZM (2001) Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 14:257\u2013279","journal-title":"Best Pract Res Clin Haematol"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI9604","volume":"105","author":"ZM Ruggeri","year":"2000","unstructured":"Ruggeri ZM (2000) Old concepts and new developments in the study of platelet aggregation. J Clin Invest 105:699\u2013701","journal-title":"J Clin Invest"},{"key":"85_CR16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0037-1614927","volume":"79","author":"AJ Vlot","year":"1998","unstructured":"Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ (1998) Factor VIII and von Willebrand factor. Thromb Haemost 79:456\u2013465","journal-title":"Thromb Haemost"},{"key":"85_CR17","first-page":"3","volume":"86","author":"M Cattaneo","year":"2001","unstructured":"Cattaneo M (2001) Role of von Willebrand factor in atherothrombosis. Haematologica 86:3\u20135","journal-title":"Haematologica"},{"key":"85_CR18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/01.ATV.0000077206.35631.B2","volume":"23","author":"A Yamashita","year":"2003","unstructured":"Yamashita A, Asada Y, Sugimura H, Yamamoto H, Marutsuka K, Hatakeyama K, Tamura S, Ikeda Y, Sumiyoshi A (2003) Contribution of von Willebrand factor to thrombus formation on neointima of rabbit stenotic iliac artery under high blood-flow velocity. Arterioscler Thromb Vasc Biol 23:1105\u20131110","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"85_CR19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","volume":"69","author":"JC Gill","year":"1987","unstructured":"Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691\u20131695","journal-title":"Blood"},{"key":"85_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365517609054464","volume":"36","author":"M Jeremic","year":"1976","unstructured":"Jeremic M, Weisert O, Gedde-Dahl TW (1976) Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest 36:461\u2013466","journal-title":"Scand J Clin Lab Invest"},{"key":"85_CR21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.18.9.1359","volume":"18","author":"PM Mannucci","year":"1998","unstructured":"Mannucci PM (1998) Von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 18:1359\u20131362","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"85_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1994.tb05079.x","volume":"88","author":"TW Meade","year":"1994","unstructured":"Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 88:601\u2013607","journal-title":"Br J Haematol"},{"key":"85_CR23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","volume":"332","author":"SG Thompson","year":"1995","unstructured":"Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 332:635\u2013641","journal-title":"N Engl J Med"},{"key":"85_CR24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.96.4.1102","volume":"96","author":"AR Folsom","year":"1997","unstructured":"Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102\u20131108","journal-title":"Circulation"},{"key":"85_CR25","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","volume":"100","author":"AR Folsom","year":"1999","unstructured":"Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK (1999) Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100:736\u2013742","journal-title":"Circulation"},{"key":"85_CR26","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","volume":"17","author":"FB Smith","year":"1997","unstructured":"Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD (1997) Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 17:3321\u20133325","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"85_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2141.1999.01317.x","volume":"105","author":"A Rumley","year":"1995","unstructured":"Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP (1995) Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart study. Br J Haematol 105:110\u2013116","journal-title":"Br J Haematol"},{"key":"85_CR28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.80.4.334","volume":"80","author":"JH Jansson","year":"1998","unstructured":"Jansson JH, Nilsson TK, Johnson O (1998) Von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10\u00a0year follow up of survivors of acute myocardial infarction. Heart 80:334\u2013337","journal-title":"Heart"},{"key":"85_CR29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","volume":"23","author":"PH Whincup","year":"2002","unstructured":"Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD (2002) Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23:1764\u20131770","journal-title":"Eur Heart J"},{"key":"85_CR30","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.19.12.3071","volume":"19","author":"A Jager","year":"1999","unstructured":"Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (1999) Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 19:3071\u20133078","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"85_CR31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","volume":"109","author":"PE Morange","year":"2004","unstructured":"Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I; on behalf of the PRIME study (2004) Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109:1343\u20131348","journal-title":"Circulation"},{"key":"85_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2141.2003.04776.x","volume":"124","author":"IM Meer van der","year":"2004","unstructured":"van der Meer IM, Brouwers GJ, Bulk S, Leebeek FW, van der Kuip DA, Hofman A, Witteman JC, Gomez Garcia EB (2004) Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study. Br J Haematol 124:343\u2013347","journal-title":"Br J Haematol"},{"key":"85_CR33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/01.CIR.0000112567.53841.10","volume":"109","author":"A Sramek","year":"2004","unstructured":"Sramek A, Bucciarelli P, Federici AB et al (2004) Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation 109:740\u2013744","journal-title":"Circulation"},{"key":"85_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(83)91115-4","volume":"74","author":"NW Stead","year":"1983","unstructured":"Stead NW, Bauer KA, Kinney TR, Lewis JG, Campbell EE, Shifman MA, Rosenberg RD, Pizzo SV (1983) Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII\/von Willebrand\u2019s factor. Am J Med 74:33\u201339","journal-title":"Am J Med"},{"key":"85_CR35","first-page":"347","volume":"152","author":"T Nilsson","year":"1986","unstructured":"Nilsson T, Mellbring G, Hedner U (1986) Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis. Acta Chir Scand 152:347\u2013349","journal-title":"Acta Chir Scand"},{"key":"85_CR36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152\u2013155","journal-title":"Lancet"},{"key":"85_CR37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","volume":"113","author":"AW Tsai","year":"2002","unstructured":"Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR (2002) Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113:636\u2013642","journal-title":"Am J Med"},{"key":"85_CR38","doi-asserted-by":"crossref","unstructured":"Bucek RA, Reiter M, Quehenberger P, Weltermann A, Kyrle PA, Minar E (2003) Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters? Br J Haematol 120:123\u2013128","DOI":"10.1046\/j.1365-2141.2003.03984.x"},{"key":"85_CR39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2141.2001.03089.x","volume":"115","author":"PW Kamphuisen","year":"2001","unstructured":"Kamphuisen PW, Eikenboom JC, Rosendaal FR, Koster T, Blann AD, Vos HL, Bertina RM (2001) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol 115:156\u2013158","journal-title":"Br J Haematol"},{"key":"85_CR40","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJM199811263392210","volume":"339","author":"JL Moake","year":"1998","unstructured":"Moake JL (1998) Moschcowitz, multimers, and metalloprotease. N Engl J Med 339:1629\u20131631","journal-title":"N Engl J Med"},{"key":"85_CR41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(85)90180-X","volume":"38","author":"Y Asada","year":"1985","unstructured":"Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K (1985) Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38:469\u2013479","journal-title":"Thromb Res"},{"key":"85_CR42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831\u2013846","journal-title":"Kidney Int"},{"key":"85_CR43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.ATV.0000058401.34021.D4","volume":"23","author":"HM Tsai","year":"2003","unstructured":"Tsai HM (2003) Deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 23:388\u2013396","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"85_CR44","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","volume":"307","author":"JL Moake","year":"1982","unstructured":"Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432\u20131435","journal-title":"N Engl J Med"},{"key":"85_CR45","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","volume":"87","author":"M Furlan","year":"1996","unstructured":"Furlan M, Robles R, L\u00e4mmle B (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223\u20134234","journal-title":"Blood"},{"key":"85_CR46","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","volume":"87","author":"HM Tsai","year":"1996","unstructured":"Tsai HM (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235\u20134244","journal-title":"Blood"},{"key":"85_CR47","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","volume":"91","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Solenthaler M, L\u00e4mmle B (1998) Acquired deficiency of von Willebrand factor cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91:2839\u20132846","journal-title":"Blood"},{"key":"85_CR48","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"key":"85_CR49","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"key":"85_CR50","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","volume":"98","author":"A Veyradier","year":"2001","unstructured":"Veyradier A, Obert B, Houllier A, Meyer D, Girma JP (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathy: a study of 111 cases. Blood 98:1765\u20131772","journal-title":"Blood"},{"key":"85_CR51","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","volume":"98","author":"K Fujikawa","year":"2001","unstructured":"Fujikawa K, Suzuki H, McMullen B, Chung D (2001) Purification of human von Willebrand factor cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98:1662\u20131666","journal-title":"Blood"},{"key":"85_CR52","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","volume":"98","author":"HE Gerritsen","year":"2001","unstructured":"Gerritsen HE, Robles R, L\u00e4mmle B, Furlan M (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98:1654\u20131661","journal-title":"Blood"},{"key":"85_CR53","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","volume":"276","author":"X Zheng","year":"2001","unstructured":"Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059\u201341063","journal-title":"J Biol Chem"},{"key":"85_CR54","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood-2002-05-1397","volume":"100","author":"B Plaimauer","year":"2002","unstructured":"Plaimauer B, Zimemrmann K, V\u00f6lkel D, Antoine G, Kerschbaumer R, Jenab P, Furlan M, Gerritsen H, Lammle B, Schwarz HP, Scheiflinger F (2002) Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 100:3626\u20133632","journal-title":"Blood"},{"key":"85_CR55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488\u2013494","journal-title":"Nature"},{"key":"85_CR56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.1992.tb08255.x","volume":"81","author":"D Bowen","year":"1992","unstructured":"Bowen D, Dasani H, Yung B, Bloom A (1992) Deep venous thrombosis and pulmonary embolism in a patient with type III von Willebrand\u2019s disease, protein C and antithrombin III deficiency. Br J Haematol 81:446\u2013447","journal-title":"Br J Haematol"},{"key":"85_CR57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1055\/s-0037-1613499","volume":"90","author":"M Franchini","year":"2003","unstructured":"Franchini M, Krampera M, Veneri D (2003) Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes. Thromb Haemost 90:963\u2013964","journal-title":"Thromb Haemost"},{"key":"85_CR58","first-page":"1455","volume":"92","author":"M Franchini","year":"2004","unstructured":"Franchini M, Veneri D (2004) Are only hemophiliacs protected against ischemic heart disease? Thromb Haemost 92:1455\u20131456","journal-title":"Thromb Haemost"},{"key":"85_CR59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<180::AID-AJH16>3.0.CO;2-G","volume":"57","author":"G Fragasso","year":"1998","unstructured":"Fragasso G, Camba L, Pizzetti G, Pagnotta P, Chierchia SL (1998) Successful thrombolysis for acute myocardial infarction in type 1 von Willebrand\u2019s disease (vWD). Am J Hematol 57:180","journal-title":"Am J Hematol"},{"key":"85_CR60","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","volume":"88","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM (2002) Venous thromboembolism in von Willebrand disease. Thromb Haemost 88:378\u2013379","journal-title":"Thromb Haemost"},{"key":"85_CR61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.56.082103.104713","volume":"56","author":"JE Sadler","year":"2005","unstructured":"Sadler JE (2005) New concepts in von Willebrand disease. Annu Rev Med 56:173\u20131791","journal-title":"Annu Rev Med"},{"key":"85_CR62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2003.00523.x","volume":"2","author":"ZM Ruggeri","year":"2004","unstructured":"Ruggeri ZM (2004) Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works. J Thromb Haemost 2:2\u20136","journal-title":"J Thromb Haemost"},{"key":"85_CR63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","volume":"84","author":"B Savage","year":"1996","unstructured":"Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289\u2013297","journal-title":"Cell"},{"key":"85_CR64","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1074\/jbc.275.11.7539","volume":"275","author":"S Miura","year":"2000","unstructured":"Miura S, Li CQ, Cao Z, Wang H, Wardell MR, Sadler JE (2000) Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion. J Biol Chem 275:7539\u20137546","journal-title":"J Biol Chem"},{"key":"85_CR65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","volume":"88","author":"M Makris","year":"2002","unstructured":"Makris M, Colvin B, Gupta V, Shields ML, Smith MP (2002) Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease. Thromb Haemost 88:387\u2013388","journal-title":"Thromb Haemost"},{"key":"85_CR66","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","volume":"99","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM, and the Alphanate Study Group (2002) Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99:450\u2013456","journal-title":"Blood"},{"key":"85_CR67","first-page":"1279","volume":"88","author":"M Franchini","year":"2003","unstructured":"Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lippi G, Manzato F, Bertuzzo D, Gandini G (2003) Efficacy and safety of factor VIII\/ von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand\u2019s disease. Haematologica 88:1279\u20131283","journal-title":"Haematologica"},{"key":"85_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1613745","volume":"83","author":"FR Rosendaal","year":"2000","unstructured":"Rosendaal FR (2000) High levels of factor VIII and venous thrombosis. Throm Haemost 83:1\u20132","journal-title":"Throm Haemost"},{"key":"85_CR69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","volume":"35","author":"PM Mannucci","year":"2004","unstructured":"Mannucci PM (2004) Treatment of von Willebrand\u2019s disease. N Engl J Med 35:683\u2013694","journal-title":"N Engl J Med"},{"key":"85_CR70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001721-200408000-00010","volume":"15","author":"IN Basso","year":"2004","unstructured":"Basso IN, Keeling D (2004) Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease. Blood Coagul Fibrinolysis 15:503\u2013504","journal-title":"Blood Coagul Fibrinolysis"},{"key":"85_CR71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00005792-198307000-00004","volume":"62","author":"LT Goodnough","year":"1983","unstructured":"Goodnough LT, Saito H, Ratnoff OD (1983) Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 62:248\u2013255","journal-title":"Medicine (Baltimore)"},{"key":"85_CR72","first-page":"1875","volume":"82","author":"MN Dulhoste","year":"1989","unstructured":"Dulhoste MN, Bonnet J, Vergnes C, Choussat A, Bricaud H (1989) Von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases. Arch Mal Coeur Vaiss 82:1875\u20131878","journal-title":"Arch Mal Coeur Vaiss"},{"key":"85_CR73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00320139","volume":"52","author":"A Girolami","year":"1986","unstructured":"Girolami A, Cappellato MG, Vicarioto MA, Casonato S, Marafioti F (1986) Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento). Blut 52:29\u201333","journal-title":"Blut"},{"key":"85_CR74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH04-02-0112","volume":"92","author":"K Dijk van","year":"2004","unstructured":"van Dijk K, van der Bom JG, Fischer K, Grobbee DE, van der Berg HM (2004) Do prothrombotic factors influence clinical phenotype of severe hemophilia? A review of the literature. Thromb Haemost 92:305\u2013310","journal-title":"Thromb Haemost"},{"key":"85_CR75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1538-7836.2004.0562e.x","volume":"2","author":"HJ Weiss","year":"2004","unstructured":"Weiss HJ (2004) The bleeding tendency in patients with low von Willebrand factor and type 1 phenotype is greater in the presence of impaired collagen-induced platelet aggregation. J Thromb Haemost 2:198\u2013199","journal-title":"J Thromb Haemost"},{"key":"85_CR76","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2004-01-0349","volume":"104","author":"TJ Kunicki","year":"2004","unstructured":"Kunicki TJ, Federici AB, Salomon DR, Koziol JA, Head SR, Mondala TS, Chismar JD, Baronciani L, Canciani MT, Peake IR (2004) An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 104:2359\u20132367","journal-title":"Blood"},{"key":"85_CR77","first-page":"121","volume":"318","author":"L Bond","year":"1988","unstructured":"Bond L, Bevan D (1988) Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med 318:121","journal-title":"N Engl J Med"},{"key":"85_CR78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","volume":"28","author":"JJ Byrnes","year":"1988","unstructured":"Byrnes JJ, Larcada A, Moake JL (1988) Thrombosis following desmopressin for uremic bleeding. Am J Hematol 28:63\u201365","journal-title":"Am J Hematol"},{"key":"85_CR79","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(89)90915-X","volume":"2","author":"PM Mannucci","year":"1989","unstructured":"Mannucci PM, Lusher JM (1989) Desmopressin and thrombosis. Lancet 2:675","journal-title":"Lancet"},{"key":"85_CR80","first-page":"664","volume":"1","author":"JM Dantzig van","year":"1989","unstructured":"van Dantzig JM (1989) Desmopressin and myocardial infarction. Lancet 1:664\u2013665","journal-title":"Lancet"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-006-0085-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-006-0085-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-006-0085-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T10:54:52Z","timestamp":1586775292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-006-0085-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,28]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s00277-006-0085-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,28]]}}}